Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions

Medicine (Baltimore). 2016 Nov;95(48):e5462. doi: 10.1097/MD.0000000000005462.

Abstract

The aim of the study was to investigate the correlation of glucose transporter-1 (Glut-1) and glucose transporter-3 (Glut-3) expression with F-18 FDG uptake in pulmonary inflammatory lesions.Twenty-two patients with pulmonary inflammatory lesions underwent positron emission tomography/computed tomography (PET/CT) examination preoperatively, and Glut-1 and Glut-3 expression were detected by immunohistochemistry in these lesions. Correlations of Glut-1 and Glut-3 with F-FDG uptake were assessed using Spearman's rank correlation test.The maximum standardized uptake value (SUVmax) of pulmonary inflammatory lesions in 22 patients was 0.50 to 7.50, with a mean value of 3.66 ± 1.62. Immunohistochemical staining scores of Glut-1 and Glut-3 were 2.18 ± 0.96 and 2.82 ± 1.37, respectively. The expression of Glut-1 and Glut-3 was positively correlated with F-18 FDG uptake. Glut-3 expression was evidently higher than Glut-1 expression in 22 patients.Glut-1 and Glut-3 expressions are high in pulmonary inflammatory lesions, and Glut-3 plays a more important role in F-18 FDG uptake in pulmonary inflammatory lesions.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Glucose Transporter Type 1 / metabolism*
  • Glucose Transporter Type 3 / metabolism*
  • Humans
  • Immunohistochemistry
  • Inflammation / diagnostic imaging
  • Inflammation / metabolism
  • Lung Diseases / diagnostic imaging*
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals / pharmacokinetics*

Substances

  • Glucose Transporter Type 1
  • Glucose Transporter Type 3
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18